Electronvolt

Improving cancer treatments - A discovery by François Légaré's team could lead to a more effective use of radiation therapy in oncology.

Retrieved on: 
Thursday, December 14, 2023
Electron, McGill University Health Centre, Research, Radiation, INRS, Plasma, Kev, Risk, MUHC, Patient, Laboratory, Neoplasm, Health, Cancer, Atmosphere, Laser & Photonics Reviews, Electronvolt, Skin, Knowledge, Professor, Travel, Medical imaging, FLASH

While research in this field may seem rather abstract at first glance, it very often leads to concrete applications.

Key Points: 
  • While research in this field may seem rather abstract at first glance, it very often leads to concrete applications.
  • This work is the result of a collaboration with medical physicists at the McGill University Health Centre (MUHC).
  • The research team was able to demonstrate that electrons accelerated in ambient air can reach energies in the MeV (megaelectronvolts) range, i.e.
  • A prime example is FLASH radiotherapy, a novel approach to treating tumours that are resistant to conventional radiation therapy.

TAU Systems signs lease on state-of-the-art premises for new Laser Plasma Accelerator Application Center - TAU Labs

Retrieved on: 
Tuesday, November 21, 2023
Research, Physics, Electronics, Biotechnology, UV, Heart, Nuclear energy, Semiconductor, TAU, Electronvolt, Laser, Life, EUV, Television

TAU Systems is developing laser-driven plasma-based particle accelerator and light sources for the semiconductor industry and research applications.

Key Points: 
  • TAU Systems is developing laser-driven plasma-based particle accelerator and light sources for the semiconductor industry and research applications.
  • Led by experts in laser-driven particle accelerators, TAU is democratizing accelerator access for the progress of semiconductors, space-bound electronics, battery technology, biotechnology, nuclear energy, and more.
  • TAU Labs will feature several laser-driven particle and light sources, as well as broad technical expertise co-located at one convenient facility.
  • Jerome Paye, TAU Systems Chief Operating Officer said "Our high repetition rate laser driver also makes TAU Labs an ideal location to test the resistance to space radiation of satellite electronics.

First ever view of the Milky Way seen through the lens of neutrino particles

Retrieved on: 
Friday, June 30, 2023
Electron, Vacuum, Radiation, Travel, Field line, IceCube Neutrino Observatory, Light, Neutron, X-ray, Ice, Electronvolt, Dust, Physics, Radio, Andromeda, Milky, Telescope, Fireworks, Science, Antarctic

Data collected by an observatory in Antarctica has produced our first view of the Milky Way galaxy through the lens of neutrino particles.

Key Points: 
  • Data collected by an observatory in Antarctica has produced our first view of the Milky Way galaxy through the lens of neutrino particles.
  • It’s the first time we have seen our galaxy “painted” with a particle, rather than in different wavelengths of light.
  • It has been speculated since antiquity that the Milky Way we see arching across the night sky consists of stars like our Sun.

Opening windows

    • Subsequently, as new astronomical windows have opened on to the sky, we have seen our galactic home in many different wavelengths of light –- in radio waves, in various infrared bands, in X-rays and in gamma-rays.
    • Neutrinos are emitted from our galaxy when cosmic rays collide with interstellar matter.
    • We do not yet definitively know all their sources, as their travel directions are scrambled by magnetic fields that exist in the space between stars.

Deep in the ice

    • Neutrinos can act as unique tracers of cosmic ray interactions deep in the Milky Way.
    • However, the ghostly particles are also generated when cosmic rays hit the Earth’s atmosphere.
    • The researchers focused on a type of neutrino interaction in the ice called a cascade.
    • These result in roughly spherical showers of light and give the researchers a better level of sensitivity to the astrophysical neutrinos from the Milky Way.

Perspective Therapeutics to Present at the 2023 International Symposium on Radiopharmaceutical Sciences (iSRS)

Retrieved on: 
Wednesday, May 24, 2023
Acetoxy group, University of Alberta, ICIS, Society, Melanoma, University, ICI, HST, TAT, Toxicity, Research, Ambiguity, Radiopharmaceutical, Avalon Ballroom, Immunotherapy, Perspective, 1991 World Sportscar Championship, Electronvolt, International Symposium on Endovascular Therapy, CATX, Cancer, Annual general meeting, Poster, Tat, Therapy, Isotope, Jan Vansina, NYSE, SPECT, Vaccine, Medical imaging, Pharmaceutical industry

RICHLAND, WASHINGTON & CORALVILLE, Iowa, May 24, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents and an innovator in seed brachytherapy treatment options for multiple cancers, today announced it will be presenting three posters at the 2023 International Symposium on Radiopharmaceutical Sciences (iSRS) Annual Meeting being held in Hawaii from May 22-26, 2023.

Key Points: 
  • "We are thrilled to present our latest research on targeted alpha therapies at the Society of Radiopharmaceutical Sciences annual meeting.
  • We believe that targeted alpha therapies have the potential to revolutionize cancer treatment, and we are committed to advancing this promising new approach."
  • said Thijs Spoor, Perspective Therapeutics’ Chief Executive Officer.
  • This enables the best possible isotopes to be utilized to keep moving us toward the goal of improved cancer therapies.

Ionetix Produces First Alpha-Emitting Radionuclide at New Isotope Production Facility

Retrieved on: 
Tuesday, April 18, 2023
Acceleration, GMP, DMF, Electronvolt, Medical Affairs Bureau, Drug Master File, Doctor of Philosophy, High-yield debt, Cyclotron, Investment, Alpha, Phosphorus, Pharmaceutical industry, Renewable energy

LANSING, Mich., April 18, 2023 /PRNewswire/ -- Ionetix, a leading cyclotron technology innovator, isotope producer and radiopharmaceutical manufacturer, announced today the successful production of Astatine-211 at its new Alpha Isotope Manufacturing facility located in Lansing, Michigan. 

Key Points: 
  • LANSING, Mich., April 18, 2023 /PRNewswire/ -- Ionetix, a leading cyclotron technology innovator, isotope producer and radiopharmaceutical manufacturer, announced today the successful production of Astatine-211 at its new Alpha Isotope Manufacturing facility located in Lansing, Michigan.
  • This first-of-its-kind facility is highly specialized and dedicated exclusively to producing alpha-emitting radionuclides using cyclotrons.
  • With extensive accelerator engineering and cyclotron operating expertise, the Ionetix team has successfully enabled the 30 MeV cyclotron for At-211 production.
  • Ionetix expects the alpha facility to be fully operational in the fourth quarter of 2023 and ready to initiate supply high-purity, non-carrier-added (n.c.a.

General Robert 'Pat' White Joins the Kronos Fusion Energy's Team as Its New CEO and is Taking on Tritium Breeding

Retrieved on: 
Monday, February 13, 2023
Operation Enduring Freedom, Army Forces Command (Germany), Train Advise Assist Command – South, National security, Military districts of the Soviet Union, International Security Assistance Force, Electronvolt, United States European Command, Commanding officer, Radio, III Corps, Operation Inherent Resolve, Support, 1st Division, Joint Chiefs of Staff, Fusion power, Absorption, Mechanized, International, RET, Division (military), Noetics, United States Army Forces Command, Fort Hood, Field line, Iraq War, Management, Lithium, Kronos, Tritium

ARLINGTON, Va., Feb. 13, 2023 (GLOBE NEWSWIRE) -- As his first order of business as the CEO of Kronos Fusion Energy, Pat is taking on building the Kronos Tritium Breeding program.

Key Points: 
  • ARLINGTON, Va., Feb. 13, 2023 (GLOBE NEWSWIRE) -- As his first order of business as the CEO of Kronos Fusion Energy, Pat is taking on building the Kronos Tritium Breeding program.
  • "Tritium plays a huge role in fusion energy generators, is used in many applications within the military, and also has many medical benefits.
  • The use of Tritium will be an essential for the commercialization of Fusion Energy.
  • While current fission-driven plants address some of the world's energy needs, creating commercializable access to fusion energy is a better long-term solution.

The Origin of High-Velocity Cloud Complex M

Retrieved on: 
Thursday, January 12, 2023
Cloud, Radio, Frank G. Ray House & Carriage House, Magellanic Stream, The Astrophysical Journal, R, Face, Complex, Cloud Nine, Perseus, Electronvolt, Compton telescope, HVC 127-41-330, Ã, Milky, Astronomy, Local Bubble, Magellanic Clouds, Human, Rotation, NASA, RADIUS, High-velocity cloud, VE, European Astronomical Society, HVC, USRA, American Astronomical Society, Telescope, Explosive, Lithium, Galaxy

WASHINGTON and SEATTLE, Jan. 12, 2023 /PRNewswire/ -- New research suggests that the High Velocity Cloud (HVC) Complex M may be the result of a supernova that blew up about four million years ago.

Key Points: 
  • WASHINGTON and SEATTLE, Jan. 12, 2023 /PRNewswire/ -- New research suggests that the High Velocity Cloud (HVC) Complex M may be the result of a supernova that blew up about four million years ago.
  • The findings will be featured in the Astrophysical Journal in a paper entitled Radio and Gamma-ray Evidence for the Supernova Origin of High Velocity Cloud Complex M : Schmelz, J.T.
  • Complex M is on the front (approaching) face.
  • "Complex M may have ridden the blast wave to reach the observed high velocities."

WIMI Hologram Academy: The Study of Holographic Communication of Dark Matter Particles

Retrieved on: 
Tuesday, July 12, 2022
Dark, Cloud, Orbit, Technology, Electronvolt, Helium, MIP, Communication, NASDAQ, Science, Calibration, Proton, Particle, Chinese Academy of Sciences, WIMI, Antimatter, Observation, Tungsten, Electron, GLOBE, WIMP, Photon, Acceleration, PSD, AI, Gamma, Silicon, Research, Physics, Nature, Absorption, Partnership, Monte Carlo, Telescope, Medical imaging, BGO

The main scientific objective of the dark matter particle detection satellite launched in China is to detect the dark matter particles indirectly through the accurate observation of high-energy cosmic-ray electrons and gamma-rays.

Key Points: 
  • The main scientific objective of the dark matter particle detection satellite launched in China is to detect the dark matter particles indirectly through the accurate observation of high-energy cosmic-ray electrons and gamma-rays.
  • Scientists from WIMI Hologram Academy of WIMI Hologram Cloud Inc.(NASDAQ: WIMI), discussed the study of dark matter particles in holographic communication.
  • To confirm the existence of dark matter particles and to understand their properties, we need to detect other interaction effects beyond their gravity.
  • AntiMatter particles in cosmic rays are preferred for detecting dark matter particles because an equal amount of positive and negative particles are usually produced if the dark matter particles annihilate or decay.

Best Medical International & TeamBest Global Will Exhibit at ASTRO 2022 Meeting in San Antonio, Texas on October 23–26

Retrieved on: 
Tuesday, October 26, 2021
Medical Supplies, Biotechnology, FDA, Health, Radiology, Pharmaceutical, Oncology, Medical Devices, Research, Science, Clinical Trials, Proton, Carbon, Proton therapy, Cyclotron, Please, PET, Medical imaging, TBG, Partners Harvard Medical International, BMI, Information, News, Electronvolt, ASTRO, Particle therapy, Radiation therapy, Online shopping

Best Medical International (BMI) & TeamBest Global Companies (TBG) are announcing they will be exhibiting at the 2022 ASTRO Meeting that will be held in San Antonio, Texas, October 2326.

Key Points: 
  • Best Medical International (BMI) & TeamBest Global Companies (TBG) are announcing they will be exhibiting at the 2022 ASTRO Meeting that will be held in San Antonio, Texas, October 2326.
  • In addition, BMI will introduce Proton Therapy Cyclotrons up to 150 MeV and 400 MeV ion Rapid Cycling Medical Synchrotrons (iRCMS) for Proton-to-Carbon Heavy Ion High Precision Radiation Therapy.
  • Best Medical International & TeamBest Global Companies' booth floorplan layout is approximately 5000 sq.
  • ft. and will be positioned near the entrance of the ASTRO 2022 exhibit space in San Antonio, Texas.

Hitachi, Tohoku University and Kyoto University Become World's First to Establish Technology for Highly Efficient, High-quality Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT

Retrieved on: 
Tuesday, October 19, 2021
Photon, Institute for Materials Research, Kyoto University, National university, Electronvolt, Association, Method, Adult, Tohoku University, Patient, Efficiency, Chemistry, Safety, Associate, Institute, Cancer, Appropriate Infrastructure Development Group, Electromagnetism, Security, Actinium-225, Nuclear medicine, KUR, Electromagnetic radiation, TAT, ELPH, European Association of Urology, KUCA, Uranium, Physics, Science, Continental Automotive Systems, Biology, Cell, Technology, Electron, Radium Girls, Medicine, Engineering, IMR, Thorium, TSE, Environment, Research institute, Radiation, Alpha, Plutonium, Quality of life, Research, Radium, Agriculture, Medical imaging, Pharmaceutical industry, Fine chemical, Fossil fuel, Microscope

Hitachi, Tohoku University, and Kyoto University will continue research and development efforts to bring this production technology into commercial use, to help put TAT into clinical practice and ultimately improve cancer patients' quality of life (QoL).

Key Points: 
  • Hitachi, Tohoku University, and Kyoto University will continue research and development efforts to bring this production technology into commercial use, to help put TAT into clinical practice and ultimately improve cancer patients' quality of life (QoL).
  • Hitachi makes effort to pursue research and development that promotes the Security & Safety (healthy and comfortable life for each individual) of society.
  • External radiation uses beams of radiation delivered outside the body to target cancer cells, while internal radiation involves internal delivery of radiation.
  • Research Center for Electron Photon Science (ELPH), Tohoku University Hidetoshi Kikunaga, Associate Professor
    Institute for Integrated Radiation and Nuclear Science, Kyoto University